🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thrilled to be at #SABCS2022 discussing exciting new data and catching up with colleagues! What an incredible time to start a career in breast oncology — much progress and much more that needs to be done for our patients. Excited to be a part of it! #bcsm

#VailWorkshop reunion at #SABCS2022 —great fun catching up friends/colleagues (missing a few in the 📸!) AACR ASCO SABCS

If you have ever been diagnosed with stage 0-3 breast cancer, please consider helping Stanford breast cancer researchers understand your perspectives on a new kind of clinical trial by filling out this short survey: bit.ly/3VXEQ6q #bcsm (retweets appreciated!)

#StanDOM's Daisuke Furukawa, Linda Geng, Ron Li, Fauzia Riaz, MD, MHS & Jorge Luis Salinas are the recipients of the first round of #TeamScience Seed Grants! We're excited to see what they accomplish with this funding! stanford.io/40YRLbG

Julie Gralow joined WPHM Radio to discuss the continued drug shortage crisis and the stressful inconsistencies its causing for patients. We need Congress to act now. Urge your representatives to take action: brnw.ch/21wF3lz #ASCOAdvocacy

Monarch-3 is complicated, huh #SABCS23 friends? Monarch-3 was small (n=493) [Paloma2 n=666, MonaLeesa2 n=668] 13.1 month improvement OS, did not reach statistical significance ⚖️If it had been larger n, would the stats have tipped? 🎨In clinic, we practice the art of medicine

Viewpoint discusses the importance of safeguarding health access in times of armed conflict worldwide and the need to bolster compliance with international humanitarian law. ja.ma/3RepsRQ

Friday at #SABCS23: Melinda Telli, MD, will deliver the second Plenary Lecture on triple-negative breast cancer. Preview her presentation in SABCS Meeting News: bit.ly/489Nm7V #BCSM Melinda Telli, M.D. AACR

#OncTwitter presentations would change if speakers had months of grade 2 diarrhea (⬆️ of 4-6 stools per day over baseline, limiting key activities of daily living) or grade 2 mucositis (moderate pain/ulcer, need modified diet). We need more patient #advocacy at 🎤. #SABCS23

My sincere thanks SABCS! We have come a long way in TNBC and it felt great to share a summary of all of those advances today. We will keep striving 🙌🏻 #SABCS23

So many wonderful breast med onc colleagues and friends to catch up with during #SABCS23 SABCS The James

Based on 4 simulation models, breast cancer screening, treatment of stage I to III breast cancer, and treatment of metastatic breast cancer were associated with reduced breast cancer mortality between 1975 and 2019 in the US. ja.ma/47EB7zR

Overlapping KM curves can sometimes be great news. In the phase 3 JBCRG-M06 trial, eribulin+HP had non-inferior PFS compared with taxane+HP in 1L HER2 MBC, with differentiated tox profile. New reasonable combination option in this setting. Congrats to the Japanese colleagues.

As my thoughtful colleagues provide advice for #ASCO25 attendees, here’s a list of stupid stuff to avoid (guilty as charged) #fiASCO 1. Wearing cute shoes. Just no. 2. Scheduling meetings in the right time zone-I screw this up and have overlapping meetings at least once a year

3. Having meetings in Hall E (or Severance Hall as Joshua Reuss has deemed it). You may never return. 4. Forgetting that McCormick has no Coca Cola products. No, Diet Pepsi is not ok. 5. Signing up for a bunch of conflicting receptions with no actual plan

Joshua Reuss 6. Settling for lattes in the exhibition hall. You can do so much better (eyes on you dippin dots ppl) 7. Waiting in the Starbucks line. I have never gotten to the front. It might not exist. 8. Not bringing your business cards after forgetting them the last 3 yrs in a row

Destiny-Breast-09 will likely establish a new first-line therapy for HER2+ MBC. Here are my considerations going into #ASCO25 Patient population considerations: 1) De novo patients (capped at 50%): these patients are more likely to respond durably and possibly even be cured in

Join me, 🌟co-fellow Nicole Dalal, Maria Antonia Vélez and others in the #ASCO25 Trainee & Early Career Lounge this weekend to discuss "Making the Most of Oncology Training"! 📅 Sunday, June 1 ⏲️ Noon - 12:45 PM CST 📍TEC Lounge in Hall C ASCO TECAG ASCO Stanford Medicine Stanford Cancer Institute

Traveling w/ mixed emotions to @asco #asco25 this yr. Celebrating science & the yrs of dedication, work, & patient contributions to cancer clinical trials. But science itself is under attack — defunding of preclinical discovery work will end up slowing our clinical advances. 1/n

The ASCO Ed Book is the highest-quality, peer-reviewed, free #oncology #MedEd ever. Whether or not you are attending #ASCO25, don’t miss out on this, #OncTwitter #MedTwitter, #MedStudentTwitter. Bookmark this tweet to keep the link handy: ascopubs.org/toc/edbk/curre… #OncoAlert